Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review
IntroductionCancer is a major global health concern, and immune checkpoint inhibitors (ICIs) offer a promising treatment option for cancer patients. However, the efficacy of ICIs can be influenced by various factors, including the use of concomitant medications.MethodsWe searched databases (PubMed,...
Main Authors: | Honglin Li, Lei Zhang, Feiran Yang, Ruohan Zhao, Xiurong Li, Huijie Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1218386/full |
Similar Items
-
The correlation between the influencing factors and efficacy of immune checkpoint inhibitor therapy: an umbrella meta-analysis of randomized controlled trials
by: Dahai Hu, et al.
Published: (2023-12-01) -
Research Progress on the Effect of Clinical Concomitant Medication on Efficacy of Immune Checkpoint Inhibitors in Urothelial Carcinoma
by: LYU Zhengqin, et al.
Published: (2024-03-01) -
Umbrella review of adjuvant photodynamic therapy for cholangiocarcinoma palliative treatment
by: Hanhan Chen, et al.
Published: (2025-02-01) -
Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses
by: Qingying He, et al.
Published: (2024-02-01) -
Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
by: Jiayuan Le, et al.
Published: (2025-12-01)